Stem Cell Therapeutics is committed to follow and maintain high standards of Corporate Governance. The Board of Directors of Stem Cell Therapeutics believes that good governance practices protect long-term shareholder value and ensures that the Company conducts its activities and operations with integrity and in an ethical manner, geared towards shareholder’s best interest. The Company aligns with the recommendations of the Toronto Stock Exchange’s Corporate Governance Guidelines as detailed in its Statement of Corporate Governance Practice (contained in the Management’s Proxy Circular).

Additional information, including Stem Cell Therapeutics financial reports and other regulatory filings can be found in the Investor Section of this web site under Financial Reports as well as on the System for Electronic Documents Analysis and Retrieval (SEDAR) at www.sedar.com